HKEX Stock Code: 01093English|繁體|简体

FY2023 Results

  • Revenue RMB31,450M, +1.7%
  • Underlying profit attributable to shareholders RMB6,275M, +2.8%
  • Profit attributable to shareholders RMB5,873M, -3.6%
  • Basic earnings per share (reported) RMB49.47 cents, -3.2%
  • Basic earnings per share (underlying profit) RMB52.86 cents, +3.2%

Highlight - FY2023

Revenue
RMB31,450M, +1.7%
Underlying profit attributable to shareholders
RMB6,275M, +2.8%
Profit attributable to shareholders
RMB5,873M, -3.6%
Basic earnings per share (reported)
RMB49.47 cents, -3.2%
Basic earnings per share (underlying profit)
RMB52.86 cents, +3.2%

Corporate Governance

Corporate Governance

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.